RICTOR and prostate carcinoma: Deletion of Rictor in mouse models for prostate cancer, or a reduction of Rictor in cancer cell lines, was shown to inhibit tumor development and cell proliferation (Hietakangas & Cohen, 2007; Masri et al, 2007; Guertin et al, 2009).